News | May 17, 2024
Biocon posts Q4 FY24 PAT at Rs. 135 Cr
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Open a printable version of this pageEmail the URL of this page to a friend
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
New leadership team announced at NATHEALTH Annual General Meeting 2024
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Subscribe To Our Newsletter & Stay Updated
